| Date | Title | Description |
| 03.11.2025 | RetinAI and the road to EssilorLuxottica: lessons from Co-Founder Carlos Ciller | RetinAI develops software that analyzes large-scale retinal images and biomarker data to support the diagnosis and monitoring of conditions such as age-related macular degeneration, glaucoma, and diabetic retinopathy. Its AI platform, Retin... |
| 16.10.2025 | EssilorLuxottica acquires RetinAI |
Bern-based RetinAI develops advanced tools to collect, process and grade large-scale retinal images and biomarker datasets. Its FDA cleared and CE-marked flagship platform, RetinAI Discovery, applies AI models to support diagnosis and moni... |
| 16.10.2025 | EssilorLuxottica Acquires RetinAI, Accelerating Transformative AI and Data-Powered Eye Health Solutions | announces the acquisition of Ikerian AG, a health technology company, operating under the RetinAI brand, specializing in AI and data management in eyecare. This move reinforces the Group’s med-tech journey, adding advanced software powered ... |
| 15.10.2025 | RetinAI acquired by EssilorLuxottica to advance AI-powered eye care | RetinAI develops innovative software that collects, processes, and analyzes large-scale retinal images and biomarker datasets. Its flagship platform, RetinAI Discovery, FDA-cleared and CE-marked, uses AI models to support the diagnosis and ... |
| 02.05.2025 | RetinAI and FVS co-developed solution obtains CE-MDR Certification |
LuxIA is designed to screen adult diabetic patients for more-than-mild diabetic retinopathy (mtmDR), providing critical support for ophthalmologists, general practitioners and trained healthcare professionals across the European Union to a... |
| 16.10.2024 | Ikerian Holds Series B Funding First Close of USD 8M | (left) Carlos Ciller, PhD, CEO, co-founder and Chairman Ikerian AG and RetinAI US Inc.; (center) Stefanos Apostolopoulos, PhD, CTO and co-founder Ikerian AG and RetinAI US Inc.; (right) Sandro De Zanet, PhD, Chief Scientific Officer and co-... |
| 03.07.2024 | Ikerian secures EU MDR Certificate for multiple assets |
Ikerian AG, the parent company of RetinAI U.S. Inc, develops software solutions for the ophthalmology and optometry market to collect, organize and analyse health data from the eyes. Its solutions, RetinAI Discovery®, a transformative heal... |
| 02.05.2024 | Ikerian AG Closes Series A Extension Financing | Ikerian AG, the parent company of RetinAI U.S. Inc., has successfully closed its Series A Extension financing, bringing in a total of USD 6.18M (CHF 5.65M) from new and existing investors. The lead investor for this final close was the Corp... |
| 02.05.2024 | Ikerian raises USD 6.18M in Series A Extension Financing round |
The final close was led by a strategic investor: the Corporate Venture Capital arm of Topcon Healthcare, Inc. The first close in 2023 added Zürcher Kantonalbank (ZKB) as a new investor alongside existing Seed and Series A venture firms, th... |
| 02.05.2024 | Ikerian secures USD 6.18 million Series A extension Financing to advance AI-driven healthcare solutions | Ikerian secures USD 6.18 million Series A extension Financing to advance AI-driven healthcare solutions 02.05.2024 09:05, Rita Longobardi linkedIn facebook twitter instagram youtube -->
Ikerian, the parent company of retinal disease anal... |
| 02.05.2024 | Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing | RetinAI Medical AG rebranded as Ikerian AG “Ikerian”, to spearhead development beyond ophthalmology, with wholly-owned subsidiary RetinAI U.S. Inc. “RetinAI” focused on the ophthalmology and optometry market.
Ikerian’s Series A Extension fi... |
| 02.05.2024 | Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A Extension Financing | - |
| 21.02.2024 | RetinAI Discovery Platform and AI tools Launched to Improve Decision Workflows, Referrals and Patient Management | Ikerian AG and RetinAI Inc. US, a leader in developing software solutions for image processing and artificial intelligence (AI) in Ophthalmology, has launched RetinAI Discovery for Clinics, with two product versions to address the needs of ... |
| 13.11.2023 | RetinAI’s Discovery platform deployed in two landmark initiatives | |
| 27.07.2023 | Swiss startups conquer new markets with global partners | |
| 25.04.2023 | RetinAI joins forces with Boehringer Ingelheim | |
| 01.12.2022 | RetinAI launches Discovery CORE™: an AI-powered, collaborative platform to accelerate Clinical & Academic Research | Features of the Discovery CORE platform displayed include the overlay of AI on OCT images to visualize fluid and layers, side-by-side imaging comparisons on two different time-points or visits, and at the bottom, progression plots for retin... |
| 30.09.2022 | RetinAI establishes presence in the US market | |
| 25.05.2022 | RetinAI and Novartis ink multi-year software license agreement | |
| 09.05.2022 | Startup internationalisation camp in the US in progress | |
| 02.05.2022 | RetinAI Discovery achieves FDA clearance | |
| 07.04.2022 | Swiss Economic Award: Das sind die Finalisten | |
| 06.08.2021 | RetinAI on a fast-paced growth course | RetinAI has developed a data management platform, Retinai Discovery®, to process health data at scale across imaging platforms and devices. With Discovery healthcare professionals can navigate multi-modal imaging data, compute AI-based imag... |
| 14.12.2020 | Meet the 38 winners of the IMD Startup Competition | The IMD Startup Competition is looking for early-stage companies that have a solid chance of market success. During the program they will enter into both strategic and business model discussions a small group of management "students&qu... |
| 14.12.2020 | Meet the 38 winners of the IMD Startup Competition | |
| 27.03.2020 | Forbes' AI30 DACH presents nine Swiss startups | |
| 27.03.2020 | Forbes' AI30 DACH presents nine Swiss startups | Forbes has nominated 30 promising startups from the DACH region whose solutions leverage artificial intelligence (AI) in the areas of text and speech analysis, healthcare and medicine, transport, software development, travel, space, logisti... |
| 31.10.2019 | btov raises €100m for its Industrial Tech Fund | |
| 28.08.2019 | Zentrum für translationale Medizin in Bern eröffnet | |
| 11.06.2019 | Swiss-founded healthtech startup RetinAI raises €2 million | Bern-based health data analysis startup RetinAI has landed CHF 2.3 million in a funding round led by btov Partners, with participation of Swiss-based investor network investiere and a consortium of private investors. The startup plans to us... |
| 11.06.2019 | CHF 2.3M investment for bringing Artificial Intelligence to Health Data | |
| 11.06.2019 | Eye-Health Startup RetinAI Raises CHF 2.3 Million to Globalize its AI-Ophthalmology | Eye-Health Startup RetinAI Raises CHF 2.3 Million to Globalize its AI-Ophthalmology 11.06.2019 13:30, Guillaume Tinsel linkedIn facebook twitter instagram youtube -->
The $8 billion market for diagnosing and monitoring eye diseases is ju... |
| 07.06.2019 | CAScination wins the Swiss Medtech Award 2019 | |
| 15.05.2019 | >>Venture>> finalists to contest for a cash prize of CHF 350000 | |
| 25.03.2019 | Sleepiz and VIU sweep to success at the Start Summit | |
| 19.03.2019 | Thirteen Swiss startups receive Eurostars grants | |
| 11.09.2018 | Venturelab and digitalswitzerland present top 13 startups to international investors | |
| 08.06.2018 | Digital health startups with their fingers on the pulse | Digital health startups with their fingers on the pulse 08.06.2018 13:45, Robynn Weldon linkedIn facebook twitter instagram youtube -->
Health tech is perhaps the sector with the most obvious potential to change our daily lives. Whether ... |
| 09.05.2018 | Ten startup founders are set for China | |
| 20.12.2017 | CHF 130’000 awarded to medtech and cleantech startups | |
| 14.07.2017 | RetinAI Medical and IbtiCare win the second stage of Venture Kick | RetinAI Medical and IbtiCare win the second stage of Venture Kick 14.07.2017 09:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
The two startup projects and their teams win CHF 20’000 each. They are now getting ready for t... |
| 14.07.2017 | RetinAI Medical and IbtiCare win the second stage of Venture Kick | RetinAI Medical and IbtiCare win the second stage of Venture Kick 14.07.2017 09:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
The two startup projects and their teams win CHF 20’000 each. They are now getting ready for t... |
| 06.06.2017 | >>venture>> finalists determined | |
| 21.04.2017 | Six venture kickers will fly to Boston for an investors’ roadshow in June 2017 | Dicronis, Patrizia Marschalkova (Medtech, ETHZ)
Lymphedema is a frequently occurring and serious complication of cancer therapies. It is a chronic and progressive disease, mostly outlined by the swelling of a limb due to improper function o... |
| 04.04.2017 | The venture leaders Life Science 2017 (the Swiss National Startup Team Life Science) at a glance | Comphya, Rodrigo Araujo Fraga da Silva (Medtech, EPFL)
Comphya develops an active implantable medical device to restore the erectile function of patients who are non-responsive to oral drugs (e.g. Viagra or Cialis). To achieve erection, the... |
| 04.04.2017 | Ten new Swiss startups are getting ready for the venture leaders Life Science investors roadshow 2017 in Boston | Leaving to Boston on June 11 until June 17, this year’s venture leaders Life Science forming the “Swiss National Startup Team Life Science 2017” reflect the impressive quality of Swiss startups, whose innovations come from the best universi... |
| 04.04.2017 | Ten new Swiss startups are getting ready for the venture leaders Life Science investors roadshow 2017 in Boston | Ten new Swiss startups are getting ready for the venture leaders Life Science investors roadshow 2017 in Boston 04.04.2017 14:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
Ten new Swiss Life Science startups have been se... |
| 04.04.2017 | Ten start-ups selected for the venture leaders Life Science program in Boston | |
| - | Retinai | “RetinAI develops solutions to generate and organize insights and knowledge to improve patient outcomes.” |
